Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center	5U54CA272686-04
Clare, Susan E.	Northwestern University At Chicago United States	Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype	1R21CA288676-01A1
Cocucci, Emanuele	Ohio State University United States	A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL	5R01CA270251-03	Matthew Young, Ph.D.
Cohen, Lorenzo	University Of Tx Md Anderson Can Ctr United States	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery	5R01CA272565-03	Brennan Streck, Ph.D., RN, M.P.H.
Cohn, Barbara A	Public Health Institute United States	Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer	5R01CA264519-05	Howard L. Parnes, M.D.
Cook, Linda S	University Of Colorado Denver United States	NOT-CA-24-111 Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)	3UG1CA286941-02S1	Elyse LeeVan, M.D., M.P.H.
Cremer, Miriam	Cleveland Clinic Lerner Com-Cwru United States	Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)	5R01CA266059-04	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Crowder, Sylvia	H. Lee Moffitt Cancer Ctr & Res Inst United States	The MIND-BC Study: MIND diet for Breast cancer Cognition	1R01CA299480-01	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Curtis, Amarinthia E	Spartanburg Regional Medical Center United States	Upstate Carolina Consortium - Community Oncology Research Program	3UG1CA239762-06S1	Vanessa A. White, M.P.H.
Curtius, Kathleen M.	University Of California, San Diego United States	Multiscale modeling of spatiotemporal evolution in Barrett's esophagus	5R01CA270235-03	Asad Umar, D.V.M., Ph.D.
Czerniak, Bogdan A	University Of Tx Md Anderson Can Ctr United States	Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy.	1P01CA296429-01A1	Howard L. Parnes, M.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy	1R21CA296516-01	Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-03	Rachel Altshuler, Ph.D.
Daniel-Macdougall, Carrie	University Of Tx Md Anderson Can Ctr United States	Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma	5R01CA291965-02	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	Immunoepigenetic targeting of MHC regulators in FAP	5R01CA257559-03